Previous studies have largely been confined to changes occurring in goblet cells, with little attention being given to the more numerous columnar epithelial cells. The aims of this study were: (1) to investigate the degree of colonic phenotypic change in pouch mucosa using three monoclonal antibodies which recognise components of the two major epithelial cell types in the colorectum-goblet and columnar cells-and to correlate this with the severity of morphological and inflammatory change within the pouch; (2) to confirm previous findings that changes in goblet cells only occur after ileostomy closure; and; (3) to assess whether any changes in the columnar cells occur before or after ileostomy closurewhether they are related to the presence of faecal stasis.
Methods
This study was approved by the Central Oxford Research Ethics Committee. Pouch biopsy specimens were assessed from 31 patients (30 with ulcerative colitis and one with familial adenomatous polyposis). Biopsy specimens from eight patients were taken before and from 23 after (eight weeks to eight years) ileostomy closure. All biopsy specimens were taken from the posterior wall of the pouch 10 cm above the dentate line. They were compared with nine cases of active ulcerative colitis (six biopsy specimens, three resections) as well as normal large bowel (n = 2) and normal terminal ileum (n = 7) taken from specimens resected for carcinoma. Immunohistochemistry was carried out on 5 gum frozen sections with the primary monoclonal antibodies PR1A3, 3A5, and 5D56 7 (courtesy of the Imperial Cancer Research Fund, London) (table 1), using a three stage immunoperoxidase technique modified from that described by Mason and Sammons.8 PR3A5 and 5D5 react with constituents of mucus glycoproteins. In the case of PR3A5 this is a colon specific form of 0-acetyl sialic acid. PR1A3 reacts strongly with colonic columnar cells but only shows focal weak positivity with normal terminal ileum. The antibodies were supplied as culture supernatant fluid preserved with 0-05% azide and were used neat. Sections were thawed, fixed in acetone for 10 minutes, and dried in air for at least 15 minutes. Endogenous peroxidase activity was blocked by immersing the slides in a solution of 3% hydrogen peroxide in 01% sodium azide. After washing in TRISbuffered saline (TBS) the sections were exposed to either the primary antibody or to TBS alone for one hour. They were then sequentially incubated for 30 minutes each with rabbit anti-mouse immunoglobulin (Dakopatts UK) diluted 1 in 50 with a 1 in 3 solution of normal swine serum in TBS and peroxidase conjugated swine anti-rabbit immunoglobulin (Dakopatts UK) diluted 1 in 100. The end product was visualised with diaminobenzidine (0-5 mg/ml) in the presence of 0-03% hydrogen peroxide. The sections were lightly counterstained with haematoxylin, dehydrated in alcohol, cleared in xylene and mounted in DPX (BDH laboratory supplies). Tissue from the normal large bowel served as a positive control. All sections were assessed by a single observer (AC) who did not know whether the pouch biopsy specimens were taken before or after closure. Strength of staining of goblet and columnar cells was graded from 0 to 3 +, where 0 was negative and 3 + was strongly positive involving most of the cells. Loss of villous height in the pouch biopsy specimens was assessed in the following manner. Measurements of total mucosal thickness (TMT) and crypt depth (CD) were taken from routine haematoxylin and eosin stained sections using a calibrated eye piece (Leitz) at a magnification of x 100. Measurements were only taken where the muscularis mucosae could be clearly identified (17 biopsy specimens, four before and 13 after closure). A minimum of three measurements were taken per specimen (mean 3-778, median 3, range 3-9) and the mean values used to calculate the villous height (VH) and an index of villous atrophy (VH/TMT).9 Acute (ulceration 0-3, neutrophil polymorph infiltration 0-3) and chronic (loss of villous height 0-3, chronic inflammatory cell infiltrate 0-3) inflammatory changes were assessed by the same observer, using an established scoring system for pouchitis.1 10 Grouped data were expressed as median and range. (fig 1) . Seven of the eight (88%) pre-closure biopsy specimens were completely negative with PR3A5 but one showed positive staining in occasional goblet cells. Fifteen out of 23 (65%) post-closure biopsy specimens showed variable degrees of positivity with this antibody (fig 2) . Total mucosal thickness, crypt depth, and the index of villous atrophy were all significantly increased in the post-closure specimens compared with the pre-closure pouch biopsy specimens (p < 0 01) (table 2), but did not show any correlation with PR1A3 and 3A5 expression. The index of villous atrophy correlated well with the subjective assessment of villous height used in the pouchitis score (rs = -0-632; p = 0 007). There were no significant differences in the pouchitis scores between biopsy specimens before and after closure, and only one of the post-closure specimens fulfilled the histological criteria for pouchitis (table 3) . However, there was a significant correlation between increasing pouchitis score and increased staining with both PR1A3 and 3A5 (rs = 0-406, 0-411; and p = 0-023 and 0-021, respectively) ( fig 3) . Increased staining with PR1A3 correlated with both increasing score for chronic inflammation (rs = 0-410; p = 0 022) and with the subjective assessment of loss of villous height Table 2 Comparing indices of villous atrophy 
useful as a model in which to study the aetiology of ulcerative colitis because possible pathogenic mechanisms can be studied from the time of pouch formation. However, despite the acquisition of some colonic features, ileal function seems to be quite well maintained in the pouch. Pouch mucosa retains disaccharidase activity (sucrase isomaltase) in the brush border, and nutritional studies on patients with pouchitis have shown normal fat absorption and serum folate concentration with decreased absorption of xylose, lactulose, and iron in only a proportion of cases (up to 30%)."1 12 Colonic metaplasia, if present, must therefore be incomplete.
The main functional difference between pouches and conventional ileostomies (in which "colonic metaplasia" is not seen) is the presence of faecal stasis. In general, metaplastic changes only seem to occur following ileostomy closure and they stabilise within three months.4 A recent study has shown that "colonic metaplasia" is greatest on the posterior wall of the pouch where stasis is maximal.2 Similar changes can be seen proximal to Crohn's strictures.5 However, pouch emptying studies have not shown any relation between incomplete emptying and the degree of "colonic metaplasia" or of "pouchitis".4 O Therefore, although faecal stasis probably contributes to the changes seen in pouch mucosa, other factors such as bacterial overgrowth may be involved. The focal distribution and incomplete nature of colonic metaplasia seen in biopsy specimens from multiple sites in the ileal pouch prompted Shepherd et al to hypothesise that acquisition of colonic type mucin is a non-specific response to pouch inflammation rather than representing true colonic metaplasia.2
Previous studies have tended to concentrate on changes in the goblet cell mucin, although acquisition of colonic ultrastructural characteristics in pouch mucosa (cell type not specified) has been described.'3 We were able to investigate changes occurring in both goblet and columnar cells in pouch mucosa using the monoclonal antibodies PRIA3, 3A5, and 5D5 (table 1) , and to assess these in biopsy specimens taken either before or after ileostomy closure. The antibodies used were developed by Richman and Bodmer as markers for colonic tumour differentiation and characterisation.67 PR5D5 stains goblet cells throughout the gastrointestinal tract, whereas PR3A5 reacts with colon specific 0-acetyl sialic acid and is not present in normal ileum. Shepherd et al have shown that up to 78% of biopsy specimens from multiple sites in the ileal pouch (after ileostomy closure) show a degree of positive staining with PR3A5. In the present study 65% of post-closure biopsy specimens from a single site on the posterior wall of the pouch were positive with this antibody. Only one of the pre-closure specimens showed any positivity and then only in occasional goblet cells. The patient from whom this biopsy specimen was taken was known to have a pouch-vaginal fistula and the biopsy specimen showed chronic inflammatory changes with a pouchitis score of 5. In the series as a whole increased staining with PR3A5 correlated with increasing pouchitis score but this seemed to be due to its association with loss of villous height rather than an increase in the amount of chronic inflammation. This finding suggests that while acquisition of colonic type mucin by the pouch may be a non-specific response to inflammation, it may also represent true adaptive change. As in most cases the change to colonic type mucin occurs after ileostomy closure; faecal stasis may be a contributory factor.
PR1A3 reacts with a surface antigen present in the membrane, apical cytoplasmic region, and microvillous brush border of columnar cells on the surface and upper crypts of colonic mucosa. It has only a faint and focal reaction in normal terminal ileum compared with strong diffuse staining in the colon. 99mTC labelled PR1A3 has been used for the imaging of colorectal cancer'4 but not in the assessment of pouch biopsy specimens. In this study columnar cells showed strong colonic type staining with PR1A3 both before and after pouch closure, indicating that in contrast to the situation in goblet cell mucus, change to a colonic phenotype can occur in columnar cells before ileostomy closure and therefore before exposure to the faecal stream. This finding is further evidence that factors other than faecal stasis may be responsible for acquisition of colonic characteristics within the pouch. As all our patients had a loop ileostomy their pouches may have been exposed to a small quantity of faecal material before ileostomy closure. Although there is unlikely to be major clinically relevant stasis, the bacterial flora of the pouch may become altered at an early stage with consequent adaptive change in the columnar epithelial cells. An altered ratio of anaerobes to aerobes may determine the magnitude of pathological change within the established pouch, but the precise role of bacteria in the acquisition of colonic characteristics by the pouch mucosa and in the pathogenesis of pouchitis remains uncertain.'5 16 As with PR3A5, staining for PR1A3 showed a positive correlation with the pouchitis score. In contrast to the situation for PR3A5, however, there was a significant correlation with the score for chronic inflammation as well as that for loss of villous height. Two of the pre-closure biopsy specimens showing strong staining with PR1A3 had "pouchitis" scores of 5 and 6 (both with acute scores of 1), respectively. Although these were not sufficient for a histological diagnosis of "pouchitis" (this requires a total score of >8 or an acute score of >4), they still indicate the presence of moderate chronic inflammatory change. In one of these patients the inflammation was known to be secondary to a pouchvaginal fistula (which has since healed); in the other the aetiology was unknown. Pouch inflammation before ileostomy closure has
